Evaluating the efficacy, safety and tolerability of serelaxin when added to standard therapy in asian patients with acute heart failure: The RELAX-AHF-ASIA trial | |
Sato, N.; Lam, C. S.; Teerlink, J. R.; Greenberg, B. H.; Tsutsui, H.; Oh, B. H.; Zhang, J.; Hua, T. A.; Wang, X. L.; Ge, J. | |
2015 | |
卷号 | 17期号:,SI页码:41-41 |
ISSN号 | 1388-9842 |
URL标识 | 查看原文 |
收录类别 | SCIE |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/6662314 |
专题 | 中国医学科学院 北京协和医学院 |
推荐引用方式 GB/T 7714 | Sato, N.,Lam, C. S.,Teerlink, J. R.,et al. Evaluating the efficacy, safety and tolerability of serelaxin when added to standard therapy in asian patients with acute heart failure: The RELAX-AHF-ASIA trial[J],2015,17(,SI):41-41. |
APA | Sato, N..,Lam, C. S..,Teerlink, J. R..,Greenberg, B. H..,Tsutsui, H..,...&Ge, J..(2015).Evaluating the efficacy, safety and tolerability of serelaxin when added to standard therapy in asian patients with acute heart failure: The RELAX-AHF-ASIA trial.,17(,SI),41-41. |
MLA | Sato, N.,et al."Evaluating the efficacy, safety and tolerability of serelaxin when added to standard therapy in asian patients with acute heart failure: The RELAX-AHF-ASIA trial".17.,SI(2015):41-41. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论